SME support to evaluate innovative medical technologies: round 5
30 Sep 2019, 00:00
11 Dec 2019, 12:00
Total £1.5m available. The total eligible project costs can be up to £100,000 for planning or up to £500,000 for studies, of which applicants can apply for up to 50% grant funding.
Office for Life Sciences (part of Innovate UK)
The Office for Life Sciences (OLS) will work with Innovate UK, part of UK Research and Innovation, to invest up to £1.5 million in innovation projects. These will support developers of innovative medical devices, diagnostics and regulated digital technologyto evaluate their product in a real world clinical setting.
All projects must be led by a UK based SME. You can choose from 2 options:
- Planning and preparation for a study, for which total eligible project costs can be up to £100,000.
- A study to collect clinical performance and cost-effectiveness data, for which total project costs can be up to £500,000.
This competition provides support for micro, small or medium sized enterprises (SMEs) to develop an evidence base for products that address NHS priorities. Our support will allow companies to collect and analyse clinical performance and cost effectiveness data in an NHS setting.
Applications are highly encouraged from SMEs from across all regions of England, Scotland, Wales, and Northern Ireland.
The total eligible project costs can be up to £100,000 for option 1 and up to £500,000 for option 2.
You can apply for funding of up to 50% of the total eligible project costs. Therefore, option 1 applications can claim a grant of up to £50,000. Option 2 applications can claim a grant of up to £250,000.
Projects must start by 1 May 2020 and must be completed by the end of April 2021.
Projects must have a total duration of between 3 and 12 months.
You cannot claim funding to cover the costs of material or capital usage. Leave these sections blank in your application.
To lead a project or work alone you must:
- be a UK registered SME
- carry out your project within the NHS
- have a product that is aligned with at least one of the NHS’s priority healthcare areas, such as those reviewed in the NHS Long Term Plan
- have a product that is already available for the NHS to purchase, but that has been marketed in the UK for less than 5 years
- outline relevant discussions you have had with the main stakeholders, such as the National Institute for Health Research (NIHR), National Institute for Health and Care Excellence and Academic Health Science Networks (AHSNs), to demonstrate the feasibility of your proposal
- have gained a CE marking for your product
Priority will be given to projects that are related to:
- ageing well
- digital transformation
- learning disabilities and autism
- mental health
- personalised care
- primary care
- starting well